New preprint: looking at rifampicin-resistant subpopulations in clinical samples Philip Fowler, 10th April 202510th April 2025 Since clinical samples are usually grown in a MGIT tube for a while before some “crumbs” are harvested for DNA extraction, they are metagenomic in the sense that they can and do contain multiple colonies. This means we should expect subpopulations in our analysis but most bioinformatics tools and file formats inherently assume a homogenous sample with a single genome. In this preprint Viki Brunner examines the small proportion of samples with a rifampicin-resistant subpopulation in a dataset of 35,538 samples which have been both whole genome sequenced and tested for rifampicin susceptibility. The sensitivity of resistance prediction is increased from 94.3% to 96.3% if you allow samples with 5% or more of reads supporting a rifampicin (RIF) resistant associated variant (RAV) to call resistance, as opposed to the more usual 75% or 90%. Drawing on her earlier work she shows that these samples with a RIF RAV are less likely to have a compensatory mutation elsewhere in the RNA polymerase and, interestingly, if you then look at the distribution of minor alleles you can infer that resistance arose from a secondary infection in at least a third of these samples. Share this: Click to share on X (Opens in new window) X Click to share on Bluesky (Opens in new window) Bluesky Click to email a link to a friend (Opens in new window) Email Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Mastodon (Opens in new window) Mastodon Related antimicrobial resistance clinical microbiology publication tuberculosis
antimicrobial resistance New software: gemucator 4th September 20184th September 2018 Short for “Genbank Mutation Locator”. A simple Python3 package that if you pass it a… Share this: Click to share on X (Opens in new window) X Click to share on Bluesky (Opens in new window) Bluesky Click to email a link to a friend (Opens in new window) Email Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance Successful NIHR grant 29th June 20185th August 2018 Last year I coordinated a bid to the NIHR for capital to improve our research… Share this: Click to share on X (Opens in new window) X Click to share on Bluesky (Opens in new window) Bluesky Click to email a link to a friend (Opens in new window) Email Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New Publication: Predicting whether mutations confer resistance to an antibiotic 5th January 201829th September 2018 Due to the rise of antibiotic resistance, it is increasingly important that your clinician knows… Share this: Click to share on X (Opens in new window) X Click to share on Bluesky (Opens in new window) Bluesky Click to email a link to a friend (Opens in new window) Email Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Mastodon (Opens in new window) Mastodon Read More